SNCA and Parkinson disease: Thus, expression of both wild-type and mutant α-synuclein reduces ER–mitochondria associations and the VAPB–PTPIP51 interaction in a number of different assays and this includes in dopaminergic neurons derived from familial Parkinson’s disease patients carrying SNCA gene triplication.